6:09AM Pharmacyclics beats by $0.06, misses on revs (PCYC) 26.80 : Reports Q3 (Mar) loss of $0.14 per share, $0.06 better than the Capital IQ Consensus Estimate of ($0.20); revenues fell 6.3% year/year to $1.93 mln vs the $3.91 mln consensus.
Market Data 
Markets 
AI
